Escitalopram and Outcomes Among Patients With Depression and Heart Failure-Reply

JAMA. 2016 Oct 11;316(14):1494-1495. doi: 10.1001/jama.2016.13888.

Authors

Christiane E Angermann¹, Jürgen Deckert², Georg Ertl³

Affiliations

¹ Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
² Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.
³ Department of Medicine I (Cardiology), University Hospital Würzburg, Würzburg, Germany.

PMID: 27727381
DOI: 10.1001/jama.2016.13888

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Citalopram / therapeutic use*
Depression*
Depressive Disorder / drug therapy
Depressive Disorder, Major / drug therapy
Double-Blind Method
Heart Failure / drug therapy
Humans
Selective Serotonin Reuptake Inhibitors / therapeutic use
Treatment Outcome

Substances

Serotonin Uptake Inhibitors
Citalopram